1-3 of 3
Eric D. Peterson
Close
Sort by
Journal Articles

Comparative Effectiveness, Safety, and Costs of Rivaroxaban and Warfarin Treatment Among Morbidly Obese Patients with Venous Thromboembolism

Alex C. Spyropoulos, MD, Veronica Ashton, MPH, Yen-Wen Chen, Bingcao Wu, Eric D. Peterson
Journal: Blood
Blood (2018) 132 (Supplement 1): 2537.
https://doi.org/10.1182/blood-2018-99-115144
Published: 2018
Journal Articles

Practice Gaps and Barriers To Optimal Care Among Hematologists and Medical Oncologists Treating Patients With Chronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), and B-Cell Lymphomas In The United States: Results Of a Two-Phase Qualitative/Quantitative Study

Kevin L. Obholz, PhD, Patrice Lazure, MSc, Andrew Bowser, ELS, CCMEP, Sophie Péloquin, MMedSc, Sean M. Hayes, PsyD, Jim Mortimer, Eric D. Peterson, EdM, FACEHP, B. Douglas Smith, MD
Journal: Blood
Blood (2013) 122 (21): 774.
https://doi.org/10.1182/blood.V122.21.774.774
Published: 2013
Journal Articles

Clinical Impact of an Internet-Based Tool to Help Guide Therapeutic Changes While Monitoring Patients with Chronic Myeloid Leukemia Receiving First-Line Tyrosine Kinase Inhibitor Therapy

Kevin L. Obholz, PhD, Daniel J. DeAngelo, MD, PhD, Michael J. Mauro, MD, Neil Shah, MD, PhD, B. Douglas Smith, MD, Andrew Bowser, ELS, CCMEP, Eric D. Peterson, EdM, FACEHP, Jerald P. Radich, MD
Journal: Blood
Blood (2012) 120 (21): 4279.
https://doi.org/10.1182/blood.V120.21.4279.4279
Published: 2012